-
British Journal of Haematology Jun 2017
Topics: Adolescent; Biopsy; Blood Cell Count; Bone Marrow; Exercise; Humans; Male; Pancytopenia
PubMed: 28419423
DOI: 10.1111/bjh.14648 -
British Journal of Haematology May 2018
Topics: Anemia, Megaloblastic; Erythropoiesis; Humans; Infant; Male; Pancytopenia; Point Mutation; Transcobalamins
PubMed: 29368379
DOI: 10.1111/bjh.15104 -
Internal Medicine Journal Sep 2012
Topics: Adult; Blood Transfusion; Bone Marrow; Diet; Dyspnea; Erythrocyte Indices; Feeding Behavior; Fever; Folic Acid; Folic Acid Deficiency; Humans; Male; Pancytopenia
PubMed: 24020347
DOI: 10.1111/j.1445-5994.2012.02849.x -
Blood Jun 2009
Topics: Aged; Humans; Male; Pancytopenia; Splenic Diseases
PubMed: 19514107
DOI: 10.1182/blood-2009-01-201327 -
Annales de Biologie Clinique Jun 2019Hematologic involvement is a common manifestation during systemic lupus erythematosus (SLE). Pancytopenia represents an infrequent mode of revelation, most often of...
Hematologic involvement is a common manifestation during systemic lupus erythematosus (SLE). Pancytopenia represents an infrequent mode of revelation, most often of peripheral origin, exceptionally secondary to a bone marrow disorder and particularly to an autoimmune myelofibrosis (AIMF). This entity, distinct from a primary myelofibrosis (MFP), is characterized by reticulin fibrosis of the bone marrow lack of atypical bone marrow cells, the presence of auto-antibodies and absence of classical signs of myeloproliferation. Generally the AIMF associated to the SLE had a favorable evolution and appears to often respond to corticosteroids and/or immunosuppressive treatments. This case illustrates the original association of an SLE revealed by a pancytopenic MFAI in a male patient with a dramatic improvement under corticosteroids.
Topics: Adult; Autoimmune Diseases; Diagnosis, Differential; Humans; Lupus Erythematosus, Systemic; Male; Pancytopenia; Primary Myelofibrosis
PubMed: 31219422
DOI: 10.1684/abc.2019.1443 -
Archives of Disease in Childhood Feb 1986Pancytopenia after intramuscular iron-dextran treatment occurred in an infant with Down's syndrome. Haematological abnormalities recurred on subsequent challenge....
Pancytopenia after intramuscular iron-dextran treatment occurred in an infant with Down's syndrome. Haematological abnormalities recurred on subsequent challenge. Positive migration inhibiting factor and mast cell degranulation tests support an allergic pathogenesis for the pancytopenia. These side effects have not been reported previously.
Topics: Down Syndrome; Female; Humans; Infant; Iron-Dextran Complex; Pancytopenia
PubMed: 2937372
DOI: 10.1136/adc.61.2.194 -
Semergen Sep 2019
Topics: Aged; Dermatologic Agents; Humans; Male; Methotrexate; Pancytopenia
PubMed: 30935832
DOI: 10.1016/j.semerg.2018.12.002 -
Annals of Hematology Sep 2023
Topics: Humans; Pancytopenia; Antibodies, Monoclonal, Humanized; Syndrome; Sepsis
PubMed: 37365299
DOI: 10.1007/s00277-023-05335-x -
International Journal of Gynaecology... Jul 2015
Topics: Adult; Blood Cell Count; Blood Transfusion; Bone Marrow; Female; Humans; Malnutrition; Pancytopenia; Pregnancy
PubMed: 25887943
DOI: 10.1016/j.ijgo.2015.02.020 -
Journal of Clinical Oncology : Official... Jan 2020
Topics: Healthcare Disparities; Hispanic or Latino; Humans; Male; Middle Aged; Military Medicine; Narration; Pancytopenia; Primary Myelofibrosis; Stem Cell Transplantation
PubMed: 31664879
DOI: 10.1200/JCO.19.01497